News and Announcements
Cirrus Materials presents to investors at the recent NZTE Singapore Technology Investment Showcase Event
- Published June 10, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Cirrus was fortunate to meet and pitch to A-list investors at the recent Technology Investment Showcase in Singapore in May. This exclusive event was arranged and underwritten by NZ Government agency New Zealand Trade and Enterprise (NZTE) with the aim of attracting strategic catalytic investment to high growth potential NZ businesses.
Cirrus attracted great interest during the event, and now has a strong investor group forming around a core of specialist investors with deep knowledge of the functional, high-performance coatings space. Singapore is a growing hub for innovative and disruptive companies that are seeking growth capital to unleash their potential on the international stage.
In New Zealand, NZTE works closely with advanced technology institute Callaghan Innovation to select and support businesses that are investment-ready and are most likely to become global growth stories. Cirrus is pleased to be heading towards the NZTE fast track for global technology firms with high growth potential.
For investors this was an opportunity to hear from some of the ecosystem’s most innovative companies at an early stage of their development, and operating in sectors where they hold a compelling competitive advantage.
About Cirrus
Cirrus is a New Zealand-based materials design business serving major manufacturing customers in Australasia, US, EU and Asia.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
